01 8Avastin
02 2Avastin
03 2Aybintio
04 4Mvasi
05 2Pobevcy
06 4Zirabev
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 798
2019 Revenue in Millions : 127
Growth (%) : 528
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 7,285
2018 Revenue in Millions : 7,054
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 143
2019 Revenue in Millions : 1
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 5,562
2019 Revenue in Millions : 7,881
Growth (%) : -29
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 1,166
2020 Revenue in Millions : 798
Growth (%) : 46
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 444
2020 Revenue in Millions : 143
Growth (%) : 210
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 3,289
2020 Revenue in Millions : 5,292
Growth (%) : -39
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 40
2021 Revenue in Millions : 1
Growth (%) : 2,599
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 39
2021 Revenue in Millions : 36
Growth (%) : 8
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 901
2021 Revenue in Millions : 1,166
Growth (%) : -23
